Article info
PDFPostScript
Letter
Proton pump inhibitors and the risk of severe COVID-19: a post-hoc analysis from the Korean nationwide cohort
- Correspondence to Dr. Dong Keon Yon, Seoul National University College of Medicine, Seoul 03080, Korea (the Republic of); yonkkang{at}gmail.com
Citation
Proton pump inhibitors and the risk of severe COVID-19: a post-hoc analysis from the Korean nationwide cohort
Publication history
- Received November 19, 2020
- Revised November 27, 2020
- Accepted November 30, 2020
- First published December 10, 2020.
Online issue publication
September 08, 2021
Article Versions
- Previous version (10 December 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage